Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous esketamine during cesarean section to prevent postpartum depression
ChiCTR2200065206Phase 4Recruiting
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postpartum depression (PPD) (2 arms), sponsored by Southern Medical University Zhujiang Hospital. Primary endpoint: Incidence of postpartum depression (EPDS score). Started Oct 2022; status: recruiting.
02
Drugs
esketamine
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR2200065206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065206.